Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure

Loris Pironi*, Ezra Steiger, Francisca Joly, Geert J.A. Wanten, Cecile Chambrier, Umberto Aimasso, Anna Simona Sasdelli, Kinga Szczepanek, Amelia Jukes, Miriam Theilla, Marek Kunecki, Joanne Daniels, Mireille J. Serlie, Sheldon C. Cooper, Florian Poullenot, Henrik Højgaard Rasmussen, Charlene W. Compher, Adriana Crivelli, Sarah Jane Hughes, Lidia SantarpiaFrancesco William Guglielmi, Nada Rotovnik Kozjek, Lars Ellegard, Stéphane M. Schneider, Przemysław Matras, Alastair Forbes, Nicola Wyer, Anna Zmarzly, Marina Taus, Margie O'Callaghan, Emma Osland, Ronan Thibault, Cristina Cuerda, Lynn Jones, Brooke Chapman, Peter Sahin, Núria M. Virgili, Andre Dong Won Lee, Paolo Orlandoni, Konrad Matysiak, Simona Di Caro, Maryana Doitchinova-Simeonova, Luisa Masconale, Corrado Spaggiari, Carmen Garde, Aurora E. Serralde-Zúñiga, Gabriel Olveira, Zeljko Krznaric, Estrella Petrina Jáuregui, Ana Zugasti Murillo, José P. Suárez-Llanos, Elena Nardi, André Van Gossum, Simon Lal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Background and aim No marker to categorise the severity of chronic intestinal failure (CIF) has been developed. A 1-year international survey was carried out to investigate whether the European Society for Clinical Nutrition and Metabolism clinical classification of CIF, based on the type and volume of the intravenous supplementation (IVS), could be an indicator of CIF severity. Methods At baseline, participating home parenteral nutrition (HPN) centres enrolled all adults with ongoing CIF due to non-malignant disease; demographic data, body mass index, CIF mechanism, underlying disease, HPN duration and IVS category were recorded for each patient. The type of IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorised as <1, 1-2, 2-3 and >3 L/day. The severity of CIF was determined by patient outcome (still on HPN, weaned from HPN, deceased) and the occurrence of major HPN/CIF-related complications: intestinal failure-associated liver disease (IFALD), catheter-related venous thrombosis and catheter-related bloodstream infection (CRBSI). Results Fifty-one HPN centres included 2194 patients. The analysis showed that both IVS type and volume were independently associated with the odds of weaning from HPN (significantly higher for PN <1 L/day than for FE and all PN >1 L/day), patients' death (lower for FE, p=0.079), presence of IFALD cholestasis/liver failure and occurrence of CRBSI (significantly higher for PN 2-3 and PN >3 L/day). Conclusions The type and volume of IVS required by patients with CIF could be indicators to categorise the severity of CIF in both clinical practice and research protocols.

Original languageEnglish
Pages (from-to)1787-1795
Number of pages9
Issue number10
StatePublished - 1 Oct 2020


  • intestinal failure
  • liver failure
  • motility disorders
  • parenteral nutrition
  • short bowel syndrome


Dive into the research topics of 'Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure'. Together they form a unique fingerprint.

Cite this